These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 31192580)

  • 21. Promotion of the anticancer activity of curcumin based on a metal-polyphenol networks delivery system.
    Chen Y; Jia D; Wang Q; Sun Y; Rao Z; Lei X; Zhao J; Zeng K; Xu Z; Ming J
    Int J Pharm; 2021 Jun; 602():120650. PubMed ID: 33957265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dual-targeting hybrid nanoparticles for the delivery of SN38 to Her2 and CD44 overexpressed human gastric cancer.
    Yang Z; Luo H; Cao Z; Chen Y; Gao J; Li Y; Jiang Q; Xu R; Liu J
    Nanoscale; 2016 Jun; 8(22):11543-58. PubMed ID: 27203688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeted biocompatible nanoparticles for the delivery of (-)-epigallocatechin 3-gallate to prostate cancer cells.
    Sanna V; Pintus G; Roggio AM; Punzoni S; Posadino AM; Arca A; Marceddu S; Bandiera P; Uzzau S; Sechi M
    J Med Chem; 2011 Mar; 54(5):1321-32. PubMed ID: 21306166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of multidrug resistant in cancer cells by EGCG, tannic acid and curcumin.
    Li H; Krstin S; Wink M
    Phytomedicine; 2018 Nov; 50():213-222. PubMed ID: 30466981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EGCG inhibits CSC-like properties through targeting miR-485/CD44 axis in A549-cisplatin resistant cells.
    Jiang P; Xu C; Chen L; Chen A; Wu X; Zhou M; Haq IU; Mariyam Z; Feng Q
    Mol Carcinog; 2018 Dec; 57(12):1835-1844. PubMed ID: 30182373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyaluronic acid-green tea catechin micellar nanocomplexes: Fail-safe cisplatin nanomedicine for the treatment of ovarian cancer without off-target toxicity.
    Bae KH; Tan S; Yamashita A; Ang WX; Gao SJ; Wang S; Chung JE; Kurisawa M
    Biomaterials; 2017 Dec; 148():41-53. PubMed ID: 28961534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Curcumin and epigallocatechin gallate inhibit the cancer stem cell phenotype via down-regulation of STAT3-NFκB signaling.
    Chung SS; Vadgama JV
    Anticancer Res; 2015 Jan; 35(1):39-46. PubMed ID: 25550533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Co-encapsulation of Epigallocatechin Gallate (EGCG) and Curcumin by Two Proteins-Based Nanoparticles: Role of EGCG.
    Yan X; Zhang X; McClements DJ; Zou L; Liu X; Liu F
    J Agric Food Chem; 2019 Dec; 67(48):13228-13236. PubMed ID: 31610115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The activity against Ehrlich's ascites tumors of doxorubicin contained in self assembled, cell receptor targeted nanoparticle with simultaneous oral delivery of the green tea polyphenol epigallocatechin-3-gallate.
    Ray L; Kumar P; Gupta KC
    Biomaterials; 2013 Apr; 34(12):3064-76. PubMed ID: 23357370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Smart nanoparticles with a detachable outer shell for maximized synergistic antitumor efficacy of therapeutics with varying physicochemical properties.
    Yin T; Liu J; Zhao Z; Dong L; Cai H; Yin L; Zhou J; Huo M
    J Control Release; 2016 Dec; 243():54-68. PubMed ID: 27702595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanoparticle Targeting CD44-Positive Cancer Cells for Site-Specific Drug Delivery in Prostate Cancer Therapy.
    Huang WY; Lin JN; Hsieh JT; Chou SC; Lai CH; Yun EJ; Lo UG; Pong RC; Lin JH; Lin YH
    ACS Appl Mater Interfaces; 2016 Nov; 8(45):30722-30734. PubMed ID: 27786455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Copper sulfide nanoparticle-based localized drug delivery system as an effective cancer synergistic treatment and theranostic platform.
    Hou L; Shan X; Hao L; Feng Q; Zhang Z
    Acta Biomater; 2017 May; 54():307-320. PubMed ID: 28274767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved anticancer effects of epigallocatechin gallate using RGD-containing nanostructured lipid carriers.
    Hajipour H; Hamishehkar H; Nazari Soltan Ahmad S; Barghi S; Maroufi NF; Taheri RA
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):283-292. PubMed ID: 29310467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Formulation, characteristics and antiatherogenic bioactivities of CD36-targeted epigallocatechin gallate (EGCG)-loaded nanoparticles.
    Zhang J; Nie S; Martinez-Zaguilan R; Sennoune SR; Wang S
    J Nutr Biochem; 2016 Apr; 30():14-23. PubMed ID: 27012617
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biocompatible Heat-Shock Protein Inhibitor-Delivered Flowerlike Short-Wave Infrared Nanoprobe for Mild Temperature-Driven Highly Efficient Tumor Ablation.
    Jiang A; Liu Y; Ma L; Mao F; Liu L; Zhai X; Zhou J
    ACS Appl Mater Interfaces; 2019 Feb; 11(7):6820-6828. PubMed ID: 30677285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergistic effects of negatively charged hydrophobic nanoparticles and (-)-epigallocatechin-3-gallate on inhibiting amyloid β-protein aggregation.
    Liu H; Yu L; Dong X; Sun Y
    J Colloid Interface Sci; 2017 Apr; 491():305-312. PubMed ID: 28049055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dual pH-responsive multifunctional nanoparticles for targeted treatment of breast cancer by combining immunotherapy and chemotherapy.
    Liu Y; Qiao L; Zhang S; Wan G; Chen B; Zhou P; Zhang N; Wang Y
    Acta Biomater; 2018 Jan; 66():310-324. PubMed ID: 29129789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergistic active targeting of dually integrin αvβ3/CD44-targeted nanoparticles to B16F10 tumors located at different sites of mouse bodies.
    Shi S; Zhou M; Li X; Hu M; Li C; Li M; Sheng F; Li Z; Wu G; Luo M; Cui H; Li Z; Fu R; Xiang M; Xu J; Zhang Q; Lu L
    J Control Release; 2016 Aug; 235():1-13. PubMed ID: 27235150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Honokiol nanoparticles based on epigallocatechin gallate functionalized chitin to enhance therapeutic effects against liver cancer.
    Tang P; Sun Q; Yang H; Tang B; Pu H; Li H
    Int J Pharm; 2018 Jul; 545(1-2):74-83. PubMed ID: 29715531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cabazitaxel and silibinin co-encapsulated cationic liposomes for CD44 targeted delivery: A new insight into nanomedicine based combinational chemotherapy for prostate cancer.
    Mahira S; Kommineni N; Husain GM; Khan W
    Biomed Pharmacother; 2019 Feb; 110():803-817. PubMed ID: 30554119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.